Combined PARP and HSP90 inhibition: preclinical and Phase 1 evaluation in patients with advanced solid tumours.
Panagiotis A KonstantinopoulosSu-Chun ChengJeffrey G SupkoMadeline PolakAndrea E Wahner-HendricksonS Percy IvyBrittany BowesHannah SawyerPatrice BasadaMartin HayesJennifer CurtisNeil HorowitzAlexi A WrightSusana M CamposElena V IvanovaCloud P PaweletzSangeetha PalakurthiJoyce F LiuAlan D' AndreaPrafulla C GokhaleDipanjan ChowdhuryUrsula A MatulonisGeoffrey I ShapiroPublished in: British journal of cancer (2021)
Combining onalespib and olaparib was feasible and demonstrated preliminary evidence of anti-tumour activity.